Ignite Creation Date:
2025-12-25 @ 3:10 AM
Ignite Modification Date:
2025-12-31 @ 3:14 PM
Study NCT ID:
NCT01597505
Status:
COMPLETED
Last Update Posted:
2019-07-23
First Post:
2012-05-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-005)
Sponsor:
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-05-16
Start Date Type:
ACTUAL
Primary Completion Date:
2015-03-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-03-20
Completion Date Type:
ACTUAL
First Submit Date:
2012-05-10
First Submit QC Date:
None
Study First Post Date:
2012-05-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-01-18
Results First Submit QC Date:
None
Results First Post Date:
2018-02-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-07-15
Last Update Post Date:
2019-07-23
Last Update Post Date Type:
ACTUAL